Pharmacogenomics of Tirzepatide: Genomic Insights into Dual GIP/GLP-1 Agonist Response in Type 2 Diabetes and Atherosclerosis.

Tirzepatide 藥物基因體學：第二型糖尿病與動脈粥狀硬化中雙重 GIP/GLP-1 促效劑反應的基因體洞見